Search Results
Search results for "fluorescent ligands"
Results found for "fluorescent ligands"
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
Unlike class A receptors, which bind orthosteric ligands within their transmembrane domain and can function Class C GPCRs carry a fundamentally different activation logic In class A receptors, the orthosteric ligand "Ligands that display biased signaling property may serve as highly specific drug candidates.
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
protein-coupled receptors using innovative approaches, including biosensors, cryo-EM, photoswitchable ligands
- Dr. Shivani Sachdev | Dr. GPCR Ecosystem
Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors
- Translating computational approaches to GPCR biologists with Dr. Riccardo Capelli | Dr. GPCR Ecosystem
held a postdoctoral position at Forschungszentrum JĂĽlich (Germany), where he worked on calculating ligand
- Brendan Wilkins | Dr. GPCR Ecosystem
This project aims to characterise the molecular pharmacology of GPR146 and to validate the proposed ligands
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
screening, and identification of small molecule regulators of these proteins, and progressing such ligands
- Dylan Eiger | Dr. GPCR Ecosystem
He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus
- Dr. Françoise Bachelerie | Dr. GPCR Ecosystem
In particular, FB contributed to the discovery that CXCL12 is the ligand for the CXCR4 receptor and can
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
Aberrant expression — a receptor in the wrong place at the wrong time, paired with autocrine or paracrine ligand are among the most robust predictive signatures for checkpoint inhibitor response — and all three are ligands
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
He established the concept of ligand-independent functions of orphan receptors in heterodimers with other
- Dr. Patrick Sexton | Dr. GPCR Ecosystem
biased agonism, and also on allosteric interactions between GPCRs and other proteins and small molecule ligands
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
receptor deorphanization used co-evolution analysis and machine learning to generate candidate peptide ligands evolutionary logic Rather than screening compound libraries blindly against orphan GPCRs, Hauser designed a ligand
- Dr. John Janetzko | Dr. GPCR Ecosystem
techniques including various mass spectrometry approaches, single particle cryo-EM and single-molecule fluorescence
- Dr. Gregory Tall | Dr. GPCR Ecosystem
Mechanical dissociation of the two fragments aided by protein binding ligands and cell movement serves
- FAQ | Dr. GPCR Ecosystem
fellows and graduate researchers entering drug discovery If you work directly with receptor systems, ligand
- Charlotte Crauwels: Designing Hybrid GPCRs with Computational Protein Engineering | Dr. GPCR Ecosystem
drug discovery, yet many receptors remain poorly characterized or “orphan,” lacking known endogenous ligands This allows researchers to activate the receptor using a known ligand while observing the signaling behavior
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
. 🗓️ Upcoming 4-Week Course: Development of GPCR Ligands as Therapeutic Drugs starting March 20 – April Highlights of the Week How Ligands Achieve Biased Signaling toward Arrestins Stéphanie Gaillard , Neha A combined in silico approach to design peptide ligands with increased receptor-subtype selectivity Adam Structural and Molecular Insights into GPCR Function A combined in silico approach to design peptide ligands with increased receptor-subtype selectivity Ligand-Independent Spontaneous Activation of Purinergic
- Dr. GPCR Team | Dr. GPCR Ecosystem
Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist Revolutionizing Protein-Ligand in Oncology and Immunology Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor prolactin-releasing peptide receptor signaling and G-protein coupling selectivity Decoding the structural basis of ligand
- GPCR Webinars | Dr. GPCR Ecosystem
Hill | Terry's Pharmacology Corner Topics Covered The biological basis of receptor signaling bias and ligand-dependent
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
interactome analysis , it’s also valuable for narrowing in on orphan GPCRs — receptors with unknown ligands
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
Yamina’s Podcast Journey and Career Advice Yamina discussed how her podcast on chemokine ligands led
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
Signaling Beyond the Receptor The dominant strategy for improving opioid therapy has been to engineer new ligands
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
determination of the β1-adrenoceptor and adenosine A2A receptor in multiple different conformations bound to ligands
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
Which ligand binds tightest, ranks highest, earns the most attention in an SAR campaign.
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
used radioligand binding methods to dissect receptor function from the adenylyl cyclase activated by ligands
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
🚀 This workshop will explore how different ligands (compounds) can stabilize unique receptor conformations 🧬 Receptor Flexibility : Ligands stabilize different receptor states, creating unique signaling pathways encourages leveraging bias for better therapeutic outcomes. 📌 Receptors are Dynamic Players 🔹 Different ligands

























